PAHC
Phibro Animal Health Corp-A
NASDAQ · Pharmaceuticals
$53.07
+3.07 (+6.14%)
Performance
1D
—
1W
+26.63%
1M
+33.24%
3M
+17.07%
6M
+71.41%
1Y
+102.40%
YTD
+42.28%
Open$50.75
Previous Close$50.00
Day High$56.30
Day Low$50.26
52W High$56.30
52W Low$16.16
Volume646.7K
Avg Volume330.0K
Market Cap2.15B
P/E Ratio31.76
EPS$1.66
SectorPharmaceuticals
Volume Analysis
1.96x average volume
Technical Indicators
SMA 50
$40.37
Above
SMA 200
$34.06
Above
RSI (14)
78.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
9 analysts
Price Target
+103.0% upside
Current
$53.07
$53.07
Target
$107.71
$107.71
$71.95
$107.71 avg
$157.72
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 1.29B | 1.16B | 1.25B |
| Net Income | 48.15M | 38.97M | 377.93M |
| Profit Margin | 3.7% | 3.5% | 30.2% |
| EBITDA | 155.71M | 133.01M | 451.24M |
| Free Cash Flow | — | — | 182.99M |
| Rev Growth | +11.2% | +11.2% | +13.2% |
| Debt/Equity | 2.52 | 2.52 | 0.35 |
Dividend
Dividend Yield0.96%
Annual Dividend$0.48
Payout Ratio40.3%
Frequencyquarterly
Ex-DividendApr 7, 2026
Pay DateApr 17, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |